NCT02379065View on ClinicalTrials.gov

Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 20, 2017

Study Completion Date

October 20, 2017

Conditions
COPD
Interventions
DEVICE

The Aerogen Aeroneb Solo©

DEVICE

Phillips Respironic© mask

Trial Locations (1)

SW10 9NH

Chelsea and Westminster Hospital, London

All Listed Sponsors
lead

Chelsea and Westminster NHS Foundation Trust

OTHER

NCT02379065 - Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter